On ECHEMI
Home > Drugs > NCPC Hebei HUAMIN Pharmaceutical Co., Ltd.
NCPC Hebei HUAMIN Pharmaceutical Co., Ltd.
  • Founded in:

    2010-04-28
  • Country:

    China China
  • Address:

    No. 98, Hainan Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130182554463533P
  • Registered Funds:

    1.450139 million yuan
  • Website:

  • Email:

Related Drugs
Roxithromycin
Roxithromycin
Name Description Content CAS NO. Registered Holders
Roxithromycin

Extract from the above information

More

Extract from the above information

80214-83-1 28
Cefadroxil
Cefadroxil
Name Description Content CAS NO. Registered Holders
Cefadroxil

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

66592-87-8 28
Cefathiamidine
Name Description Content CAS NO. Registered Holders
CEFATHIAMIDINE

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

33075-00-2 17
Cefdizime Sodium for Injection
Cefdizime Sodium
Name Description Content CAS NO. Registered Holders
Cefodizime

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

69739-16-8 1
Cefpirome Sulfate
Name Description Content CAS NO. Registered Holders
Cefpirome sulfate

No specific description provided

More

No specific description provided

98753-19-6 40
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.